DXL Board Urges AGAINST FullBeauty Merger as Bank of America ABL Financing Collapses
DXLG sits 26% above its 52-week low of $0.362 on light trading volume (0.2× avg).
Summary
DXL's board again urges shareholders to reject the FullBeauty merger, now citing Bank of America's refusal to fund the combined company's ABL facility and FBB's deepening losses. Separately, it seeks a reverse split to protect the Nasdaq listing and 13.5M more incentive-plan shares.
Key Events · M&A and Partnerships · DXLG
-
Board Recommends AGAINST Merger Issuance
The DXL Board unanimously urges a vote against the share issuance for the FullBeauty merger, which would hand FBB holders 55% of the combined company versus DXL's 45%, despite being contractually required to hold the vote.
-
Bank of America ABL Financing Collapses
Bank of America declined on September 25, 2026 to extend its commitment letter past October 14 or underwrite the Combined ABL Facility; no binding replacement is in place, only non-binding term sheets from Gordon Brothers and one other lender.
-
FBB Losses and Going-Concern Warning
FBB posted Q2 fiscal 2026 net sales of $160.6M (down 16.0%) and a $3.1M net loss, with a $29.6M first-half loss; its audited financials carry a going-concern qualification and a leverage covenant waiver running through merger consummation or termination.
-
Reverse Split Needed for Nasdaq Listing
Proposal 2 authorizes a 1-for-2 to 1-for-30 reverse split, needed to reach the $4.00 minimum bid for Nasdaq initial listing if the merger closes and to cure the $1.00 bid deficiency by the February 1, 2027 compliance deadline.
Analysis · DXLG · Trade & Services
The case against the FullBeauty merger has strengthened, and DXL's board is now telling shareholders to vote it down — even though the company remains contractually obligated to put the deal to a vote. On September 25, Bank of America refused to extend its commitment letter past October 14 or underwrite the combined company's asset-based revolver, and no binding replacement exists. The only alternatives are non-binding term sheets from Gordon Brothers and one other lender, expected to cost more, lend less and carry prepayment penalties. Without that liquidity, the combined company may not be able to fund operations after closing. DXL's board also flags FBB's deteriorating results — Q2 sales down 16% and a $29.6M first-half net loss — plus a going-concern qualification in FBB's audited financials and a leverage covenant waiver. Against that backdrop, shareholders are asked to approve a reverse split (1-for-2 to 1-for-30) needed to hold the Nasdaq listing regardless of the merger, and a 13.5M-share increase to the 2016 incentive plan. Roughly 20.8% of shares are locked into voting FOR the deal by pre-existing voting agreements, so the issuance proposal could pass even with the board opposed.
How filings like this one have moved
In the 30 days to Oct 19, 2026, 43.2% of the 271 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.30%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DXLG was trading at $0.46 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $25.3M. The 52-week trading range was $0.36 to $1.58. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.